Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
552.08
436.66
1,881.66
1,801.23
855.66
206.87
178.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
552.08
436.66
1,881.66
1,801.23
855.66
206.87
178.24
Raw Material Cost
272.16
231.20
891.72
695.52
219.76
121.07
112.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
95.14
90.53
168.08
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.85
0.84
1.19
1.36
1.00
1.19
1.36
Selling and Distribution Expenses
81.06
71.16
73.67
71.45
63.65
37.51
32.54
Other Expenses
-3.34
-1.09
-6.11
6.06
4.03
1.57
0.83
Total Expenditure (Excl Depreciation)
416.80
382.84
1,073.60
828.89
324.73
175.43
154.90
Operating Profit (PBDIT) excl Other Income
135.29999999999998
53.8
808.1
972.3000000000001
530.9000000000001
31.400000000000002
23.3
Other Income
83.86
119.52
169.18
8.34
-10.71
4.16
5.33
Operating Profit (PBDIT)
218.98
152.62
945.13
979.78
520.92
38.42
28.07
Interest
1.85
0.84
1.19
1.36
1.00
1.19
1.36
Exceptional Items
1.84
-6.16
-18.71
0.84
-0.00
-0.01
-0.01
Gross Profit (PBDT)
279.92
205.46
989.94
1,105.71
635.90
85.80
65.54
Depreciation
22.72
29.28
23.33
10.63
5.59
4.95
4.16
Profit Before Tax
196.24
116.34
901.90
968.63
514.33
32.27
22.53
Tax
28.14
10.58
128.33
132.87
79.36
4.33
3.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
169.52
106.61
773.63
833.59
435.15
28.23
18.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
169.52
106.61
773.63
833.59
435.15
28.23
18.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.74
-1.31
-0.07
2.17
-0.18
-0.29
-0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
166.78
105.30
773.56
835.76
434.97
27.94
18.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,409.48
2,415.24
2,561.24
2,107.10
444.14
126.96
98.86
Earnings per share (EPS)
1.16
0.72
5.18
5.58
2.91
0.19
0.13
Diluted Earnings per share
1.16
0.72
5.18
5.58
2.91
0.19
0.13
Operating Profit Margin (Excl OI)
20.36%
0.87%
40.0%
53.34%
61.48%
14.17%
10.42%
Gross Profit Margin
39.66%
33.35%
49.17%
54.37%
60.76%
17.99%
14.98%
PAT Margin
30.7%
24.41%
41.11%
46.28%
50.86%
13.65%
10.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 26.43% vs -76.79% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 58.40% vs -86.39% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 308.16% vs -95.73% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 125.00% vs -33.33% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Hangzhou Biotest Biotech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
552.08
0
552.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
552.08
0
552.08
Raw Material Cost
272.16
0
272.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
95.14
0
95.14
Power Cost
0
0
0.00
Manufacturing Expenses
1.85
0
1.85
Selling and Distribution Expenses
81.06
0
81.06
Other Expenses
-3.34
0.00
-3.34
Total Expenditure (Excl Depreciation)
416.80
0
416.80
Operating Profit (PBDIT) excl Other Income
135.29
0.00
135.29
Other Income
83.86
0
83.86
Operating Profit (PBDIT)
218.98
0
218.98
Interest
1.85
0
1.85
Exceptional Items
1.84
0
1.84
Gross Profit (PBDT)
279.92
0
279.92
Depreciation
22.72
0
22.72
Profit Before Tax
196.24
0
196.24
Tax
28.14
0
28.14
Provisions and contingencies
0
0
0.00
Profit After Tax
169.52
0
169.52
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
169.52
0
169.52
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.74
0
-2.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
166.78
0
166.78
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,409.48
0
2,409.48
Earnings per share (EPS)
1.16
0
1.16
Diluted Earnings per share
1.16
0
1.16
Operating Profit Margin (Excl OI)
20.36%
0%
0.00
20.36%
Gross Profit Margin
39.66%
0%
0.00
39.66%
PAT Margin
30.70%
0%
0.00
30.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 55.21 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 26.43% vs -76.79% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 16.68 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 58.40% vs -86.39% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.51 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 308.16% vs -95.73% in Dec 2023
Annual - Interest
Interest 0.18 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 125.00% vs -33.33% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.36%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






